Partnership between "M42" and"10X Health" and"Revive Global" To launch the 10XREVIV precision health platform
Abu Dhabi, 5 November / WAM / M42, a global leader in the fields of technology-enabled health, artificial intelligence and genomic sciences, announced the signing of a strategic partnership with “10X Health” from the United States of America, and “REVIV Global” from the United Kingdom, to launch the pioneering “10X REVIV” project, which is expected to create a qualitative shift in the fields of precision health, nutrition and long life.
This partnership aims to offer one of the most advanced precision nutrition systems in the world through the 10XREVIV platform in the Middle East region, as it combines genetic analysis, blood biomarkers and nutritional sciences, supported by advanced artificial intelligence technologies, to provide highly personalized health solutions aimed at improving the quality of life on a large scale.
The core of the collaboration is based on the 10X Precision System, a patented life sciences platform developed over more than a decade by leading biotech and data science scientists. The system also relies on special artificial intelligence algorithms capable of analyzing up to 20 million genetic variants with 99.97% accuracy, as the platform combines DNA data, blood chemistry and lifestyle factors, to form the unique biological fingerprint of each individual.
The platform produces more than 400 pages of secure digital health reports, containing accurate and actionable insights on nutrient absorption, metabolic efficiency, inflammation, immune function, cardiovascular health, and pathways to longevity.
The 10XREVIV platform translates complex findings into clinical evidence-based therapeutic interventions, including 10X Precision Supplements: innovative microbead formulations featuring up to 22 micronutrients, 10X Precision Weight Management Solutions: specialized programs for carbohydrate and lipid regulation, and Precision Intravenous Therapy: based on genetic data to deliver precise doses of micronutrients, administered exclusively through licensed and certified medical facilities.
In addition to launching the precision nutrition system, the partnership will also include the opening of a major precision health and long life clinic in the region, in addition to implementing a controlled clinical trial to study the effect of intravenous nutrition therapy on patients with type 2 diabetes, in addition to launching a training program in the field of precision nutrition to enable doctors to interpret genetic data and apply it in clinical practice, which contributes to improving patient outcomes.
Al-Baraa Al-Khani, Chief Operating Officer of the Integrated Health Solutions Platform at M42, confirmed that this partnership represents a qualitative step towards redefining the future of healthcare, explaining that the company seeks to integrate artificial intelligence, data and life sciences to enable humans to achieve their fullest potential. He pointed out that the cooperation with the companies “10X Health” and “Reve Global” is a pivotal step in developing accurate, predictive and preventive healthcare, as insights extracted from genes and biomarkers allow determining the best ways of nutrition. Restore balance and enhance the performance of the human body.
For his part, Brandon Dawson, co-founder, chairman and CEO of 10X Health, explained that the cooperation with M42 and Revive Global opens new horizons for expanding the application of the precision nutrition system in one of the most advanced and future-proof health systems in the world.
He added that this joint step establishes a new global standard in the field of improving human capabilities, by combining science, technology and clinical applications in one integrated system.
Sarah Lomas, founder and CEO of Revive Global, confirmed that the new collaboration combines advanced genetic analysis, nutrition programs supported by artificial intelligence, and world-class clinical applications, indicating her enthusiasm to bring these advanced solutions to the Middle East region and contribute to shaping the future of precise health and long life.
- For more: Follow Khaleejion 24 Arabic, Khaleejion 24 English, Khaleejion 24 Live, and for social media follow us on Facebook and Twitter
